Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»Australia»Ariadne Australia Sells Interests in Port Macquarie, Batemans Bay Marinas
    Ariadne Australia
    Australia

    Ariadne Australia Sells Interests in Port Macquarie, Batemans Bay Marinas

    Business News AsiaBy Business News AsiaMarch 24, 2016No Comments1 Min Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Ariadne Australia Limited (ASX:ARA) has announced that it has completed the sale of its interests in both the Port Macquarie and Batemans Bay marinas.

    In a disclosure to the Australian Securities Exchange (ASX), Ariadne Australia Limited executive director Gary Weiss said the sale of Port Macquarie and Batemans Bay marinas was for $3.5 million and in line with book value.

    As part of the transaction, the bank debt associated with the Port Macquarie marina was repaid, further reducing the group’s overall financial leverage.

    Ariadne Australia Limited is an investment company listed on the Australian Securities Exchange (ASX:ARA), with operations in Australia and New Zealand.

    The Company is engaged in investing in securities, car parking, financial services, property and maritime operations.

    Ariadne’s objective is to hold a portfolio of assets and investments in order to provide attractive investment returns, which can generate dividends to shareholders and capital growth in the value of the shareholders’ investments. – BusinessNewsAsia.com

    Ariadne Australia ASX:ARA Australia Stock Exchange Batemans Bay Port Macquarie
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleCebu Airport Launches China, Taiwan Direct Flights
    Next Article Norwest Energy CEO Peter Munachen Quits

    Related Posts

    Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

    October 19, 2021

    Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

    October 14, 2021

    Ashley Black’s FasciaBlaster, America’s #1 Beauty Tool, Launches Into Australian Markets

    October 5, 2021
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.